This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Endocannabinoids in End Stage Renal Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Allon Friedman, Indiana University
ClinicalTrials.gov Identifier:
NCT01477515
First received: November 18, 2011
Last updated: August 21, 2012
Last verified: August 2012
  Purpose
To investigate the relationship between dietary intake, body habitus, and endocannabinoid levels in end stage renal disease patients as compared to matched controls.

Condition
End Stage Renal Disease Nutrition

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Allon Friedman, Indiana University:

Enrollment: 30
Study Start Date: February 2012
Groups/Cohorts
End stage renal disease patient
Matched controls

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Hemodialysis patients healthy control subjects
Criteria

Inclusion Criteria:

  • hemodialysis patient, able to give informed consent

Exclusion Criteria:

  • hospitalization in past 3 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Allon Friedman, Assistant Professor of Medicine, Indiana University
ClinicalTrials.gov Identifier: NCT01477515     History of Changes
Other Study ID Numbers: ANF-1
Study First Received: November 18, 2011
Last Updated: August 21, 2012

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency

ClinicalTrials.gov processed this record on September 21, 2017